XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative effect, period of adoption, adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Nov. 02, 2019   368,302          
Beginning balance at Nov. 02, 2019   $ 61,385 $ 4,936,349 $ 6,899,253 $ 2,379 $ (187,799) $ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 471,570     471,570      
Dividends declared and paid       (427,760)      
Issuance of stock as charitable contribution (in shares)   336          
Issuance of stock as charitable contribution   $ 56 39,944        
Issuance of stock under stock plans and other (in shares)   1,838          
Issuance of stock under stock plans and other   $ 306 30,591        
Stock-based compensation expense     73,401        
Other comprehensive income (loss) $ (86,824)         (86,824)  
Common stock repurchased (in shares)   (2,051)          
Common stock repurchased   $ (342) (219,272)        
Ending balance (in shares) at May. 02, 2020   368,425          
Ending balance at May. 02, 2020   $ 61,405 4,861,013 6,945,442   (277,002)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting standards update [extensible list] us-gaap:AccountingStandardsUpdate201802Member            
Beginning balance (in shares) at Feb. 01, 2020   368,220          
Beginning balance at Feb. 01, 2020   $ 61,371 4,923,947 6,906,346   (202,147)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 267,696     267,696      
Dividends declared and paid       (228,600)      
Issuance of stock under stock plans and other (in shares)   1,347          
Issuance of stock under stock plans and other   $ 224 14,560        
Stock-based compensation expense     35,900        
Other comprehensive income (loss) (74,855)         (74,855)  
Common stock repurchased (in shares)   (1,142)          
Common stock repurchased   $ (190) (113,394)        
Ending balance (in shares) at May. 02, 2020   368,425          
Ending balance at May. 02, 2020   $ 61,405 4,861,013 6,945,442   (277,002)  
Beginning balance (in shares) at Oct. 31, 2020   369,485          
Beginning balance at Oct. 31, 2020 11,997,945 $ 61,582 4,949,586 7,236,238   (249,461)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 811,424     811,424      
Dividends declared and paid       (483,608)      
Issuance of stock under stock plans and other (in shares)   1,644          
Issuance of stock under stock plans and other   $ 274 43,398        
Stock-based compensation expense     76,996        
Other comprehensive income (loss) 66,546         66,546  
Common stock repurchased (in shares)   (2,302)          
Common stock repurchased   $ (384) (345,487)        
Ending balance (in shares) at May. 01, 2021   368,827          
Ending balance at May. 01, 2021 12,167,104 $ 61,472 4,724,493 7,564,054   (182,915)  
Beginning balance (in shares) at Jan. 30, 2021   368,894          
Beginning balance at Jan. 30, 2021   $ 61,484 4,849,185 7,395,578   (218,501)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 422,905     422,905      
Dividends declared and paid       (254,429)      
Issuance of stock under stock plans and other (in shares)   1,155          
Issuance of stock under stock plans and other   $ 192 23,560        
Stock-based compensation expense     40,358        
Other comprehensive income (loss) 35,586         35,586  
Common stock repurchased (in shares)   (1,222)          
Common stock repurchased   $ (204) (188,610)        
Ending balance (in shares) at May. 01, 2021   368,827          
Ending balance at May. 01, 2021 $ 12,167,104 $ 61,472 $ 4,724,493 $ 7,564,054   $ (182,915)